If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
23rd Sep 20102:20 pmRNSTransfer of Treasury Shares
17th Sep 20107:00 amRNSTransaction in Own Shares
15th Sep 201010:54 amRNSTransfer of Treasury Shares
15th Sep 20107:00 amRNSTransaction in Own Shares
13th Sep 201012:21 pmRNSTransfer of Treasury Shares
13th Sep 201012:16 pmRNSInterim Report 30 June 2010
9th Sep 20107:00 amRNSTransaction in Own Shares
7th Sep 20103:22 pmRNSTransfer of Treasury Shares
2nd Sep 20109:50 amRNSDirector/PDMR Shareholding
31st Aug 201010:52 amRNSDirector/PDMR Shareholding
26th Aug 201011:40 amRNSShare Buy-Back Programme
26th Aug 20107:00 amRNSInterim results
3rd Aug 20102:12 pmRNSBlocklisting Interim Review
3rd Aug 20102:10 pmRNSBlocklisting Interim Review
3rd Aug 20102:05 pmRNSTotal Voting Rights
19th Jul 20103:15 pmRNSBlocklisting Interim Review
19th Jul 20103:14 pmRNSBlocklisting Interim Review
9th Jul 20107:00 amRNSAcquisition
7th Jul 201012:43 pmRNSHolding(s) in Company
7th Jul 201012:41 pmRNSHolding(s) in Company
5th Jul 201012:21 pmRNSDirector/PDMR Shareholding
1st Jul 20103:28 pmRNSTotal Voting Rights
30th Jun 20102:42 pmRNSScrip dividend / Additional Listing
30th Jun 20102:34 pmRNSTransfer of Treasury Shares
23rd Jun 20107:00 amRNSHolding(s) in Company
22nd Jun 201012:09 pmRNSNotice of Results
17th Jun 20101:45 pmRNSHolding(s) in Company
16th Jun 20109:24 amRNSTransfer of Treasury Shares
14th Jun 20109:21 amRNSHolding(s) in Company
3rd Jun 201010:12 amRNSScrip Dividend Alternative
2nd Jun 20109:29 amRNSDirectors' Other Directorships
1st Jun 20102:03 pmRNSBlocklisting Interim Review
1st Jun 20102:01 pmRNSBlocklisting Interim Review
1st Jun 20101:59 pmRNSBlocklisting Interim Review
1st Jun 20101:52 pmRNSTotal Voting Rights
25th May 20108:44 amRNSDirectors' Other Directorships
24th May 20109:26 amRNSHolding(s) in Company
17th May 20107:00 amRNSTransaction in Own Shares
13th May 201012:50 pmRNSDirector/PDMR Shareholding
13th May 201012:44 pmRNSResult of AGM
11th May 20107:00 amRNSInterim Management Statement
11th May 20107:00 amRNSTransaction in Own Shares
4th May 20102:14 pmRNSAnnual Information Update
4th May 20102:10 pmRNSTotal Voting Rights
30th Apr 20107:00 amRNSTransaction in Own Shares
29th Apr 20107:00 amRNSTransaction in Own Shares
28th Apr 20107:00 amRNSTransaction in Own Shares
23rd Apr 20107:00 amRNSTransaction in Own Shares
21st Apr 20108:24 amRNSDirector/PDMR Shareholding
21st Apr 20107:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.